Clinical Trials Directory

Trials / Completed

CompletedNCT02051452

Reversal of General Anesthesia With Methylphenidate

Reversal of General Anesthesia With Intravenous Methylphenidate

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate whether methylphenidate (Ritalin) can actively induce emergence from general anesthesia in patients having a pancreaticoduodenectomy (Whipple procedure), a pancreatectomy, or a prostatectomy.

Conditions

Interventions

TypeNameDescription
DRUGMethylphenidate
OTHERSaline

Timeline

Start date
2014-11-01
Primary completion
2018-05-01
Completion
2018-05-01
First posted
2014-01-31
Last updated
2019-08-22
Results posted
2019-08-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02051452. Inclusion in this directory is not an endorsement.

Reversal of General Anesthesia With Methylphenidate (NCT02051452) · Clinical Trials Directory